You are viewing the site in preview mode

Skip to main content

Table 4 (Abstract P41).

From: 31st Annual Meeting and Associated Programs of the Society for Immunotherapy of Cancer (SITC 2016): part one

Tumor Number of patient tumors Average yield (and range) or TILs from pre-REP (106)
Bladder 2 290 (97-600)
Cervical 4 360 (147-800)
H&N 7 539 (132-738)
Lung 8 688 (50-915)
TNBC 13 429 (81-665)
Back to article page